Guardant Health (GH)
What the price implies
A reverse DCF: instead of guessing a fair value, it asks what growth today's price already assumes. How it works.
Fundamental grade
Five factors scored 1 to 9 from GH's latest numbers, weighted into one grade. It describes the business, not whether the stock is a buy.
Key numbers
Results from SEC filings
Fiscal years, from Guardant Health's 10-K filings. The deep dive has 15+ years, quarters and every line.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $374M | $450M | $564M | $739M | $982M |
| Net income | -$385M | -$655M | -$479M | -$436M | -$416M |
| Free cash flow | -$284M | -$387M | -$345M | -$275M | -$233M |
| EPS (diluted) | -$4.00 | -$6.41 | -$4.28 | -$3.56 | -$3.32 |
| Operating margin | -110.0% | -121.1% | -100.1% | -60.0% | -44.5% |
Where the revenue comes from
Revenue by products, fiscal 2025.
Superinvestors who own GH
From each investor's latest 13F filing (what a 13F shows). 6 of the investors we track hold it.
| Investor | Last quarter | Value | % of portfolio | Quarter |
|---|---|---|---|---|
| Tom Steyer Farallon Capital Management LLC |
Added | $48M | 0.22% | Q2 2026 |
| Hersh Cohen ClearBridge Investments |
New position | $42M | 0.04% | Q2 2026 |
| Cliff Asness AQR Capital Management |
Trimmed | $18M | 0.01% | Q2 2026 |
| Joel Greenblatt Gotham Asset Management |
New position | $3M | 0.01% | Q2 2026 |
| Ron Baron Baron Capital (BAMCO) |
Trimmed | $2M | 0.00% | Q2 2026 |
| Eric Marshall Hodges Capital Management |
New position | $2M | 0.12% | Q2 2026 |
Insider buying
Open-market purchases by Guardant Health's executives and directors in the last 12 months, from SEC Form 4 filings. What insider buying tells you.
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Nov 21, 2025 | Sheldon Whitehouse |
0 | $105.42 | — |
| Nov 21, 2025 | Sheldon Whitehouse |
0 | $105.42 | — |
Get an alert at your buy price
Pick the price you'd be interested at. We'll email you when GH trades at or below it.
Free accounts get 3 price alerts. No card needed.
In the full deep dive
Questions
Are Guardant Health insiders buying the stock?
2 open-market insider purchases of GH in the last 12 months, from SEC Form 4 filings.
Which superinvestors own Guardant Health?
6 of the superinvestors Investingly tracks hold GH in their latest 13F, including Tom Steyer, Hersh Cohen, Cliff Asness.
Prices and ratios as of Oct 7, 2026; statements from SEC filings. Information only, not investment advice. Superinvestor holdings come from 13F filings, which are filed up to 45 days after each quarter ends.